Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cyanotech Corporation (CYAN : OTC)
 
 • Company Description   
CYANOTECH CORP. develops and commercializes natural products from microalgae. Co. is currently producing microalgae products for the nutritional supplement and immunological diagnostics markets and is also developing microalgae-based products for the aquaculture feed/pigments, biopesticide and food coloring markets. Microalgae are a diverse group of over 30,000 species of microscopic plants which have a wide range of physiological and biochemical characteristics and naturally contain high levels of nutrients.

Number of Employees: 83

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.30 Daily Weekly Monthly
20 Day Moving Average: 2,007 shares
Shares Outstanding: 7.39 (millions)
Market Capitalization: $2.23 (millions)
Beta: -0.24
52 Week High: $0.60
52 Week Low: $0.23
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.67% -11.06%
12 Week -0.20% -4.34%
Year To Date -17.38% -27.78%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
73-4460 QUEEN KAAHUMANU HWY SUITE 102
-
KAILUA KONA,HI 96740
USA
ph: 808-326-1353
fax: 808-329-4533
brussell@cyanotech.com http://www.cyanotech.com
 
 • General Corporate Information   
Officers
Matthew K. Custer - Chief Executive Officer and President
Michael A. Davis - Chairman
Jennifer C. Rogerson - Chief Financial Officer; Vice President and Treasu
David M. Mulder - Director
David L. Vied - Director

Peer Information
Cyanotech Corporation (GSAC)
Cyanotech Corporation (CASI)
Cyanotech Corporation (ALCD.)
Cyanotech Corporation (OMNN)
Cyanotech Corporation (CGPI.)
Cyanotech Corporation (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 232437301
SIC: 2833
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/11/25
Share - Related Items
Shares Outstanding: 7.39
Most Recent Split Date: 11.00 (0.25:1)
Beta: -0.24
Market Capitalization: $2.23 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/11/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.27
Price/Cash Flow: -
Price / Sales: 0.09
EPS Growth
vs. Year Ago Period: 23.53%
vs. Previous Quarter: -44.44%
Sales Growth
vs. Year Ago Period: -1.32%
vs. Previous Quarter: -7.62%
ROE
09/30/25 - -
06/30/25 - -32.45
03/31/25 - -33.08
ROA
09/30/25 - -
06/30/25 - -12.41
03/31/25 - -13.38
Current Ratio
09/30/25 - -
06/30/25 - 0.98
03/31/25 - 1.03
Quick Ratio
09/30/25 - -
06/30/25 - 0.22
03/31/25 - 0.27
Operating Margin
09/30/25 - -
06/30/25 - -12.13
03/31/25 - -13.23
Net Margin
09/30/25 - -
06/30/25 - -12.13
03/31/25 - -13.23
Pre-Tax Margin
09/30/25 - -
06/30/25 - -12.09
03/31/25 - -13.19
Book Value
09/30/25 - -
06/30/25 - 1.11
03/31/25 - 1.23
Inventory Turnover
09/30/25 - -
06/30/25 - 2.20
03/31/25 - 2.34
Debt-to-Equity
09/30/25 - -
06/30/25 - 0.12
03/31/25 - 0.11
Debt-to-Capital
09/30/25 - -
06/30/25 - 11.11
03/31/25 - 10.12
 

Powered by Zacks Investment Research ©